Announcement • Aug 01
Cel AI PLC Announces Intention to Cancel Listing on London Stock Exchange Cel AI PLC announced its intention to cancel: (i) the listing of the Company's Ordinary Shares ("Ordinary Shares") on the Equity Shares (Transition) category of the Official List (the "Official List") of the U.K. Financial Conduct Authority ("FCA"); and (ii) the admission to trading of its Ordinary Shares on the London Stock Exchange's ("LSE") main market for listed securities (together, the "Delisting"). As per the Company's articles of association, shareholder approval is required for the Delisting. In accordance with U.K. Listing Rule 21.2.17R, the Company is required to give at least 20 business days' notice of the Delisting. As such, conditional on the Resolutions being passed at the General Meeting, it is intended that the Delisting will become effective from 8:00 a.m. (U.K. time) on 1 September 2025, such that the last day of trading of the Ordinary Shares on the LSE will be 29 August 2025. The Company notes that the move to AQSE Growth Market is necessary in order to continue with the Bitcoin strategy which will become impracticable under the Listing Rules. Accordingly, the Directors will recommend that Shareholders vote in favour of the Resolutions at the General Meeting. Cel AI's current holding in Bitcoin remains at 5.28 BTC following a disposal of 3.42 BTC on 17 July 2025. The Company intends to continue to acquire further Bitcoin following admission to the AQSE Growth Market. Announcement • Jul 02
Cel AI PLC has completed a Follow-on Equity Offering in the amount of £10 million. Cel AI PLC has completed a Follow-on Equity Offering in the amount of £10 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 5,000,000,000
Price\Range: £0.002
Transaction Features: Subsequent Direct Listing Announcement • Jun 03
Cel AI PLC has completed a Follow-on Equity Offering in the amount of £0.25 million. Cel AI PLC has completed a Follow-on Equity Offering in the amount of £0.25 million.
Security Name: Ordinary Shares
Security Type: Common Stock
Securities Offered: 39,062,500
Price\Range: £0.0064 Announcement • Jan 31
Cel AI PLC, Annual General Meeting, Feb 25, 2025 Cel AI PLC, Annual General Meeting, Feb 25, 2025. Location: the offices of fladgate llp, 16 great queen street, wc2b 5dg, london United Kingdom Announcement • Jun 15
Cel AI PLC Appoints Timothy Le Druillenec as Executive Director Cel AI PLC announce that Timothy Le Druillenec has been appointed as Executive Director. The appointment will take effect immediately. Timothy Le Druillenec is a qualified Accountant and has acted as a director and company secretary to a number of public and private companies over many years and held main board positions on several Main Market, AIM, PLUS and Aquis companies. He has been involved with launching several companies on the Main Market of the London Stock Exchange in the cinema, home shopping, property, esports and crypto sectors. He is currently a Director of Phoenix Digital Assets Plc as well as some private companies. Current directorships and/or partnerships: Aquis Stock Exchange listed company: Phoenix Digital Assets PLC, Private: - Briarmount Limited - Venn It Systems Limited - Pllugs Limited - IO+ PTE LTD. Former directorships and/or partnerships (within the last five years): Aquis Stock Exchange listed companies: Supernova Digital Assets PLC - File Forge Technology PLC - Motto Technologies PLC - Googly Esports PLC - Punter Finance PLC. London Stock Exchange listed companies: Argo Blockchain PLC - Guild Esports PLC - Streaks AI PLC Private: Bent Tree Estates Limited. Announcement • Apr 30
Cel AI PLC Ceases Gill Whitty Collins as Non-Executive Director Cel AI announced that the Company and Gill Whitty Collins have agreed that Gill will cease to be a Non-Executive Director of the Company with effect from 30 April 2024, being the end of her fixed-term engagement with the Company. Announcement • Jan 19
Cellular Goods PLC, Annual General Meeting, Feb 13, 2024 Cellular Goods PLC, Annual General Meeting, Feb 13, 2024, at 14:00 Coordinated Universal Time. Location: Fladgate LLP at 16 Great Queen Street London: United Kingdom Reported Earnings • Dec 23
Full year 2023 earnings released: UK£0.006 loss per share (vs UK£0.012 loss in FY 2022) Full year 2023 results: UK£0.006 loss per share (improved from UK£0.012 loss in FY 2022). Net loss: UK£3.31m (loss narrowed 45% from FY 2022). Announcement • Dec 05
Cellular Goods plc Launches Luxury Gift Sets for the Christmas Season Cellular Goods plc announced the launch of its 'Look Better' skincare range festive gift sets for the Christmas season. The 'Gift Better' collection comprises the Nourish and Relax Gift Set, containing Cellular Goods' Cannabinoid Face Oil, a camomile and lavender scented candle, a luxury silk sleeping eye mask and a vegan leather reusable bag. Also available for purchase is the Rejuvenate and Indulge Gift Set, containing cellular Goods' Cannabinoid Face Serum and the Rejuvenating Night Cream, a camomile and Lavender scented candle, a Lux silk sleeping eye mask and a Vegan leather reusable vanity bag. The 'Gift Better range adds festive gifting options to the Company's gift set repertoire that already includes the Rejuvenate and Unwind, and Calm and Balance Gift Sets. New Risk • Nov 24
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended February 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£4.5m free cash flow). Share price has been highly volatile over the past 3 months (82% average daily change). Earnings have declined by 58% per year over the past 5 years. Revenue is less than US$1m (UK£47k revenue, or US$59k). Market cap is less than US$10m (€3.11m market cap, or US$3.40m). Minor Risks Latest financial reports are more than 6 months old (reported February 2023 fiscal period end). Shareholders have been diluted in the past year (19% increase in shares outstanding). Announcement • May 10
Cellular Goods PLC (LSE:CBX) acquired King Tide Carbon PTE. LTD from Matthew Lodge for £0.57 million. Cellular Goods PLC (LSE:CBX) acquired King Tide Carbon PTE. LTD from Matthew Lodge for £0.57 million on May 5, 2023. As a part of the transaction, Matthew Lodge is appointed as a non-executive director of the Cellular Goods and remains part of founding team of King Tide. First Sentinel Corporate Finance Limited acted as financial advisor to Cellular Goods PLC.
Cellular Goods PLC (LSE:CBX) completed the acquisition of King Tide Carbon PTE. LTD from Matthew Lodge on May 5, 2023. Reported Earnings • May 08
First half 2023 earnings released: UK£0.004 loss per share (vs UK£0.005 loss in 1H 2022) First half 2023 results: UK£0.004 loss per share (improved from UK£0.005 loss in 1H 2022). Net loss: UK£1.81m (loss narrowed 24% from 1H 2022). Board Change • May 08
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. CFO, Company Secretary & Director Bruna Nikolla was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Feb 10
Cannaray Brands Limited/Love CBD Health LTD cancelled the acquisition of Cellular Goods PLC (LSE:CBX). Cannaray Brands Limited/Love CBD Health LTD agreed to acquire Cellular Goods PLC (LSE:CBX)for £14.2 million on September 26, 2022. Cannaray Limited will appoint the majority of the ongoing CBX board of directors. Cellular Goods has conditionally agreed to acquire the Cannaray Subsidiaries for an initial consideration of £14.2 million, consisting of £1 million in cash, together with a number of new Cellular shares, which will make Cannaray a 54% shareholder in the enlarged group. There can be no certainty that the Transaction will proceed and it remains subject to, amongst other things, entering into a definitive legal agreement and obtaining all other necessary approvals.
Cannaray Brands Limited/Love CBD Health LTD cancelled the acquisition of Cellular Goods PLC (LSE:CBX) on February 8, 2023. Announcement • Jan 20
Cellular Goods PLC, Annual General Meeting, Feb 13, 2023 Cellular Goods PLC, Annual General Meeting, Feb 13, 2023, at 16:00 Coordinated Universal Time. Location: the offices of Fladgate LLP 16 Great Queen Street, London, WC2B 5DG London United Kingdom Announcement • Jan 07
Cellular Goods plc Announces Board Changes produced cannabinoids, announced that Peter Wall and Simon Walters, non-executive directors, have stepped down from the Board of Directors and are leaving the Company with immediate effect. Mr. Wall has stepped down to focus on pre-existing executive management positions. Mr. Walters' retirement from the Board as a NED follows Cellular's planned course of business, with Mr. Walters having served on the Board as Finance Director since November 2020. The role held by Simon changed to Non-Executive Director in September 2022 to coincide with Cellular's appointment of Bruna Nikolla as Chief Financial Officer.Following these departures, the composition of the Board is as follows: Darcy Taylor is Interim CEO and Chairman, Bruna Nikolla is Chief Financial Officer; and Misha Sher and Gill Whitty-Collins are Non-Executive Directors. Board Change • Nov 16
No independent directors There are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). Chief Strategy Officer & Director Alexis Abraham is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors. Announcement • Oct 24
Cellular Goods Announces its 'Look Better' (Skincare) Range Will Be Available for Purchase on Debenhams' Online Premium Marketplace Cellular Goods announced that its 'Look Better' (skincare) range will be available for purchase on Debenhams' online premium marketplace, Debenhams.com, from 24 October 2022. Cellular Goods will initially offer eight of its cannabinoid-based skincare products on the online marketplace, making the Company the first cannabigerol (CBG)-based skincare brand to offer its products on Debenhams.com and contributing to Cellular Goods' efforts to continue building its sales channels. With high numbers of monthly visitors to Debenhams.com, this initiative will enable Cellular Goods to widen its reach and address demand for products that can help prevent the signs of skin ageing and sensitivity. The commencement of sales on Debenhams.com follows the launch of shipping to the US, as well as the launch of Cellular Goods' four new gifting sets in the Company's new 'Gift Better' (gifting) range, for the festive season, in October. Cellular Goods' products available on Debenhams.com include the new Rejuvenating Night Cream, SPF 25 Rejuvenating Day Cream and Rejuvenating Day Mousse, which contain the Company's proprietary formulation of cannabidiol (CBD) and CBG. Other Cellular Goods products available on the Debenhams marketplace include the Company's CBG-based Nourishing Cannabinoid Face Oil, Calming Cannabinoid After Shaving Moisturiser and Rejuvenating Face Serum, as well as all 'mini' sizes for all available 'Look Better' products. Announcement • Sep 28
Cannaray Brands Limited/Love CBD Health LTD agreed to acquire Cellular Goods PLC (LSE:CBX)for £14.2 million. Cannaray Brands Limited/Love CBD Health LTD agreed to acquire Cellular Goods PLC (LSE:CBX)for £14.2 million on September 26, 2022. Cannaray Limited will appoint the majority of the ongoing CBX board of directors. Cellular Goods has conditionally agreed to acquire the Cannaray Subsidiaries for an initial consideration of £14.2 million, consisting of £1 million in cash, together with a number of new Cellular shares, which will make Cannaray a 54% shareholder in the enlarged group. There can be no certainty that the Transaction will proceed and it remains subject to, amongst other things, entering into a definitive legal agreement and obtaining all other necessary approvals. Announcement • Sep 23
Cellular Goods Announces Now Shipping Products to the USA Cellular Goods PLC announced that select products in its 'Look Better' (skincare) range are available for purchase from the Company's website for shipment to the USA for the first time. Cellular Goods has opened sales from its ecommerce website following the launch of its Rejuvenating Skincare Campaign, starring international supermodel Helena Christensen. The Company's products available for shipping to the USA include the Rejuvenating Night Cream, Rejuvenating Day Mousse and Rejuvenating Face Serum. The products contain the Company's proprietary formulation of cannabidiol (CBD) and cannabigerol (CBG), which fight the effects of inflammation, a root cause of skin ageing, without the harmful side effects associated with industry-standard ingredients retinol and vitamin C. Other products on sale include the Company's Nourishing Cannabinoid Face Oil and Calming Cannabinoid After Shaving Moisturiser, which contain ultra-pure, lab-produced CBG, as well as 'mini' sizes for all available 'Look Better' products, which are designed to be compact and convenient for travel. The products are available to buy via the Company's ecommerce website,www.cellular-goods.com,from today. Announcement • Sep 21
Cellular Goods PLC Launches Three New Skincare Products Cellular Goods announce\d a significant expansion to its 'Look Better' (skincare) range, with the launch of three new products in a campaign fronted by international supermodel Helena Christensen. Cellular Goods has expanded its Look Better range with three new Rejuvenating products, comprising the Rejuvenating Night Cream, the SPF 25 Rejuvenating Day Cream and the Rejuvenating Day Mousse, complementing the Company's Rejuvenating Cannabinoid Serum, the first and only product in the UK to use novel cannabigerol ("CBG") to provide age-preventative benefits. All three new products are formulated with Cellular Goods' proprietary blend of CBG and cannabidiol ("CBD"), which, as shown by the Company's white papers, protect the skin from UV damage and inflammation, two leading causes of skin ageing. The new products will allow the Company to widen its reach and meet demand for products that effectively address the visible signs of ageing without the irritative side effects associated with other, industry-standard ingredients such as retinoids. The night cream has a retail price of £89 for 50ml, the day cream of £79 for 50ml and the day mousse of £69 for 50ml. All three products are available for purchase on the Company's ecommerce website,www.cellular-goods.comand on the Amazon Marketplace from 21 September 2022, as well as in premium cannabinoid retailer Voyager's brick-and-mortar stores in Edinburgh, St Andrews and Dundee. Announcement • Aug 16
Cellular Goods plc Announces the Appointment of Bruna Nikolla as Chief Financial Officer Cellular Goods announced the appointment of Bruna Nikolla as Chief Financial Officer. Ms Nikolla who will also serve as Company Secretary, will become a Director and is expected to join Cellular Goods with effect from 22 August 2022. Ms Nikolla will take over from Simon Walters who will continue with his role until 1 September 2022 to ensure an orderly handover. Ms Nikolla is a member of the Chartered Institute of Management Accountants and brings more than 15 years of financial, strategic and commercial experience across multiple sectors including eCommerce, luxury retail, international technology, software and telecommunications. She has significant leadership experience within the premium consumer goods sector and previously served as Finance Director of Trinny London, a premium beauty and skincare brand founded by UK television presenter and makeover guru Trinny Woodall. During her tenure at Trinny London, Bruna led the pricing and commercial strategy in a high-growth period. Between 2018 and 2020 she served as Finance Director at luxury eyewear brand Tom Davies Ltd. where she maintained overall responsibility for controlling all UK and head office finance as well as supporting the wider operations of the business. Announcement • Jul 12
Cellular Goods Launches Minis of Rejuvenating Cannabinoid Face Serum and the Calming Cannabinoid After Shaving Moisturiser Cellular Goods announced the launch of mini-size formats for two products, the Rejuvenating Cannabinoid Face Serum and the Calming Cannabinoid After Shaving Moisturiser, in its 'Look Better' (skincare) range. The new sizes are designed to be compact and convenient for travel as well as provide an entry-level price point to encourage more consumers to trial the products or buy them as gifts, broadening the brand's footprint. The 30ml after-shaving moisturiser has a retail price of £32 and the 15ml serum retails at £54. Both are available for purchase on the Amazon Marketplace and the Company's ecommerce website. As with their full-size equivalents, the minis have been through an extensive testing process and are fully validated for marketing and labelling as suitable for sensitive skin, dermatologically tested and dermatologist approved. The entire Look Better range is formulated with cannabigerol (CBG), which the Company's white paper indicated has both antioxidant and anti-inflammatory effects, making it a skincare ingredient with powerful anti-aging potential. The after-shaving moisturiser also contains the Cellular Goods' patent-pending skin-brightening complex, which can improve skin-tone evenness associated with various factors, including melasma and hyperpigmentation. The Rejuvenating Cannabinoid Face Serum and the Calming Cannabinoid After Shaving Moisturiser use lab-made CBG, which does not require the cultivation of the cannabis sativa plant and contains 0% THC, the psychoactive component of cannabis sativa. Announcement • May 12
Cellular Goods PLC Announces Executive Changes Cellular Goods PLC announced the following changes to its board of directors, which are effective immediately. Darcy Taylor, a non-executive director ("NED") of the Company, will assume the role of non-executive chairman. He succeeds Peter Wall,who is stepping down as chairman of the Company in order to devote more time to his existing executive roles and increased commitments but will remain a NED of the Company. Gill Whitty-Collins has been appointed a NED and succeeds David Gardner, who is leaving the Board due to time commitments at his other business interests. Misha Sher has been appointed a NED in succession to Ross Connolly. Mr. Sher is a senior marketing executive with over two decades of experience working with leading brands, rights holders and talent. Board Change • Apr 27
No independent directors There are 6 new directors who have joined the board in the last 3 years. Of these new board members, none were independent directors. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). Chief Strategy Officer & Director Alexis Abraham is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Lack of board continuity. Lack of experienced directors. Announcement • Mar 03
Cellular Goods PLC Announces Launch of Rejuvenating Cannabinoid Face Serum Cellular Goods PLC announced the launch of its Rejuvenating Cannabinoid Face Serum as part of its 'Look Better' (skincare) range. Cellular Goods' Cannabinoid Face Serum is the UK's first cannabigerol-powered serum, which works to prevent the signs of aging caused by UV-light exposure and inflammation. The product contains ultra-pure, biosynthetic CBG and its development has been informed by the findings of the Company's recent white paper, which revealed that CBG has anti-inflammatory and antioxidant properties, giving it immense potential for age-prevention skincare solutions. The serum will allow the Company to meet demand for products that have demonstrated effectiveness in addressing the signs of aging without causing harmful side effects, such as irritation and photosensitivity, that industry standard active ingredients retinol and Vitamin C can produce. Cellular Goods' face serum has gone through an extensive testing process and is fully validated for marketing and labelling as suitable for sensitive skin, dermatologically tested and dermatologist approved. The product uses lab-made CBG, does not require the cultivation of the cannabis sativa plant and contains 0% THC, the psychoactive component of cannabis sativa. Announcement • Dec 01
Cellular Goods plc Announces Launch of Inaugural Products & Ecommerce Platform Cellular Goods PLC announce the launch of its inaugural product ranges and ecommerce platform, found at cellulargoods.co. The launch comprises two product ranges and comes just nine months after the start-up of the Company's commercial operations following its flotation on the London Stock Exchange. The inaugural range comprises the UK's first premium CBG (cannabigerol) skincare offering including a serum, a face-oil and an after-shaving moisturiser. The products contain ultra-pure, biosynthetic CBG, which has demonstrated anti-inflammatory, anti-oxidant and anti-bacterial properties. All three products have been through an extensive testing process and are fully validated for marketing and labelling as suitable for sensitive skin, dermatologically tested and dermatologist approved. The second range is a clinically validated CBD (cannabidiol) ingestibles range. This range complies with novel food regulations in both the UK and the EU and is certified under Good Manufacturing Practice (GMP) standards. The ingestibles range comprises a tincture, a spray and capsules, covering the most popular methods of consumption. These have been extensively tested to ensure safety, stability and quality. Recent Insider Transactions • Oct 06
CEO & Director recently bought €181k worth of stock On the 1st of October, Alexis Abraham bought around 2m shares on-market at roughly €0.091 per share. This was the largest purchase by an insider in the last 3 months. This was Alexis' only on-market trade for the last 12 months.